Literature DB >> 27868262

Adipocytes enhance expression of osteoclast adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.

Tingting Luo1,2, Hongrui Liu2, Wei Feng2, Di Liu2, Juan Du2, Jing Sun2, Wei Wang2, Xiuchun Han2, Jie Guo2, Norio Amizuka3, Xianqi Li1,4, Minqi Li2.   

Abstract

OBJECTIVES: The purpose of this study was to investigate effects of adipocytes on osteoclast adhesion-related molecules.
MATERIALS AND METHODS: ST2 cells, a cloned stromal cell line from mouse bone marrow, able to differentiate into adipocytes, were cultured in serum-free α-MEM which was then collected to be used as adipocyte-conditioned medium (ADIPO CM). RAW264.7 cells were cultured in ADIPO CM in the presence of RANKL, and bone marrow-derived macrophages were cultured in ADIPO CM in the presence of RANKL and macrophage-colony stimulating factor to induce osteoclast differentiation. TRAP staining, resorption pit assay, qRT-PCR and western blotting assays were performed.
RESULTS: ELISAs revealed that CXCL12 was abundant in ADIPO CM and CCK-8 assay revealed no proliferation of RAW264.7 cells after exogenous CXCL12 treatment. ADIPO CM enhanced osteoclast formation and resorption, both by RAW264.7 cells and BMMs. In addition, exogenous CXCL12 efficiently potentiated formation of TRAP-positive osteoclast and resorption by RAW264.7 cells. Western blotting and qRT-PCR suggested that ADIPO CM or combined treatment with exogenous CXCL12 caused significant increase in expression of NFAT2, src and osteoclast adhesion-related molecules, including β3 integrin, CD44 and osteopontin. However, these promotional effects were largely abrogated on treatment of AMD3100, a CXCR4 antagonist.
CONCLUSIONS: Adipocytes promoted osteoclast differentiation, function and expression of adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  CXCL12/CXCR4; adhesion-related molecules; adipocyte; osteoclast

Mesh:

Substances:

Year:  2016        PMID: 27868262      PMCID: PMC6529116          DOI: 10.1111/cpr.12317

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  41 in total

1.  Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.

Authors:  Ganesh V Halade; Amina El Jamali; Paul J Williams; Roberto J Fajardo; Gabriel Fernandes
Journal:  Exp Gerontol       Date:  2010-10-12       Impact factor: 4.032

2.  The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.

Authors:  M A Chellaiah; K A Hruska
Journal:  Calcif Tissue Int       Date:  2002-12-10       Impact factor: 4.333

Review 3.  The role of the chemokine CXCL12 in osteoclastogenesis.

Authors:  Stan Gronthos; Andrew C W Zannettino
Journal:  Trends Endocrinol Metab       Date:  2007-02-21       Impact factor: 12.015

4.  c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.

Authors:  Takashi Izawa; Wei Zou; Jean C Chappel; Jason W Ashley; Xu Feng; Steven L Teitelbaum
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

5.  Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.

Authors:  Minqi Li; Norio Amizuka; Kiichi Takeuchi; Paulo H L Freitas; Yoshiro Kawano; Masaaki Hoshino; Kimimitsu Oda; Kayoko Nozawa-Inoue; Takeyasu Maeda
Journal:  Microsc Res Tech       Date:  2006-02       Impact factor: 2.769

6.  Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.

Authors:  Rocky Pramanik; Xia Sheng; Brian Ichihara; Nora Heisterkamp; Steven D Mittelman
Journal:  Leuk Res       Date:  2013-01-17       Impact factor: 3.156

7.  CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts.

Authors:  Anne Chabadel; Inmaculada Bañon-Rodríguez; David Cluet; Brian B Rudkin; Bernhard Wehrle-Haller; Elisabeth Genot; Pierre Jurdic; Ines M Anton; Frédéric Saltel
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

8.  Stromal cell-derived factor-1 mediates changes of bone marrow stem cells during the bone repair process.

Authors:  Kiyotaka Okada; Naoyuki Kawao; Masato Yano; Yukinori Tamura; Shinzi Kurashimo; Katsumi Okumoto; Kotarou Kojima; Hiroshi Kaji
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-11-03       Impact factor: 4.310

Review 9.  Effects of obesity on bone metabolism.

Authors:  Jay J Cao
Journal:  J Orthop Surg Res       Date:  2011-06-15       Impact factor: 2.359

10.  Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone.

Authors:  K Merry; R Dodds; A Littlewood; M Gowen
Journal:  J Cell Sci       Date:  1993-04       Impact factor: 5.285

View more
  7 in total

1.  Adipocytes enhance expression of osteoclast adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.

Authors:  Tingting Luo; Hongrui Liu; Wei Feng; Di Liu; Juan Du; Jing Sun; Wei Wang; Xiuchun Han; Jie Guo; Norio Amizuka; Xianqi Li; Minqi Li
Journal:  Cell Prolif       Date:  2016-11-21       Impact factor: 6.831

2.  Participation of integrin β3 in osteoblast differentiation induced by titanium with nano or microtopography.

Authors:  Helena B Lopes; Gileade P Freitas; Carlos N Elias; Coralee Tye; Janet L Stein; Gary S Stein; Jane B Lian; Adalberto L Rosa; Marcio M Beloti
Journal:  J Biomed Mater Res A       Date:  2019-02-23       Impact factor: 4.396

3.  Elevated plasma CXCL12/SDF-1 levels are linked with disease severity of postmenopausal osteoporosis.

Authors:  Xian-Wen Yang; Hong-Xing Huang; Fei Wang; Qi-Lin Zhou; Yan-Qiang Huang; Ru-Zi Qin
Journal:  Innate Immun       Date:  2019-10-22       Impact factor: 2.680

4.  C‑X‑C receptor 7 agonist acts as a C‑X‑C motif chemokine ligand 12 inhibitor to ameliorate osteoclastogenesis and bone resorption.

Authors:  Alexander Patera Nugraha; Fumitoshi Ohori; Hideki Kitaura; Adya Pramusita; Saika Ogawa; Takahiro Noguchi; Aseel Marahleh; Yasuhiko Nara; Ria Kinjo; Itaru Mizoguchi
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

5.  Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis.

Authors:  Dong Ding; Jiangbo Yan; Gangning Feng; Yong Zhou; Long Ma; Qunhua Jin
Journal:  Int J Mol Med       Date:  2021-11-05       Impact factor: 4.101

6.  Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption.

Authors:  Dong Ding; Limei Wang; Jiangbo Yan; Yong Zhou; Gangning Feng; Long Ma; Yong Yang; Xiuying Pei; Qunhua Jin
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

7.  CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma.

Authors:  Mei Zhang; Min Zheng; Li Dai; Wei-Long Zhang; Hua-Yang Fan; Xiang-Hua Yu; Xin Pang; Peng Liao; Bing-Jun Chen; Sha-Sha Wang; Ming-Xin Cao; Xiang-Rui Ma; Xin-Hua Liang; Ya-Ling Tang
Journal:  J Cell Mol Med       Date:  2021-06-25       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.